Quantitative assessment of the effect of CYP2D6 genotype on tamoxifen metabolism: A model for CYP2D6 genotype-phenotype studies.

被引:0
|
作者
Borges, S [1 ]
Desta, Z [1 ]
Jin, Y [1 ]
Li, L [1 ]
Skaar, TC [1 ]
Flockhart, DA [1 ]
机构
[1] Indiana Univ, Indianapolis, IN 46204 USA
关键词
D O I
10.1016/j.clpt.2005.12.120
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P34 / P34
页数:1
相关论文
共 50 条
  • [41] Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity
    Doki, Kosuke
    Sekiguchi, Yukio
    Kuga, Keisuke
    Aonuma, Kazutaka
    Homma, Masato
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (04) : 257 - 262
  • [42] A novel CYP2D6 scoring system for the prediction of CYP2D6 activity: Application to tamoxifen metabolism.
    Borges, S.
    Li, L.
    Robarge, J.
    Nguyen, A.
    Azzouz, F.
    Desta, Z.
    Skaar, T.
    Flockhart, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S67 - S67
  • [43] Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen response
    Kiyotani, Kazuma
    Mushiroda, Taisei
    Hosono, Naoya
    Tsunoda, Tatsuhiko
    Kubo, Michiaki
    Aki, Fuminori
    Okazaki, Yutaka
    Hirata, Koichi
    Takatsuka, Yuichi
    Okazaki, Minoru
    Ohsumi, Shozo
    Yamakawa, Takashi
    Sasa, Mitsunori
    Nakamura, Yusuke
    Zembutsu, Hitoshi
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (09): : 565 - 568
  • [44] Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers
    Gonzalez, Idilio
    Penas-Lledo, Eva M.
    Perez, Barbaro
    Dorado, Pedro
    Alvarez, Mayra
    LLerena, Adrian
    PHARMACOGENOMICS, 2008, 9 (07) : 833 - 840
  • [45] Nicotine metabolism and CYP2D6 phenotype in smokers
    Caporaso, NE
    Lerman, C
    Audrain, J
    Boyd, NR
    Main, D
    Issaq, HJ
    Utermahlan, B
    Falk, RT
    Shields, P
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001, 10 (03) : 261 - 263
  • [46] Prediction of CYP2D6 phenotype from genotype across world populations
    Gaedigk, Andrea
    Sangkuhl, Katrin
    Whirl-Carrillo, Michelle
    Klein, Teri
    Leeder, J. Steven
    GENETICS IN MEDICINE, 2017, 19 (01) : 69 - 76
  • [47] CYP2D6 phenotype prediction from genotype: Which system is the best?
    Kirchheiner, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 225 - 227
  • [48] A CYP2D6 phenotype-genotype mismatch in Japanese psychiatric patients
    Ieiri, I
    Yamada, S
    Seto, K
    Morita, T
    Kaneda, T
    Mamiya, K
    Tashiro, N
    Higuchi, S
    Otsubo, K
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 192 - 196
  • [49] CYP2D6 phenotype and the metabolism of nicotine and cotinine
    Benowitz, NL
    Jacob, P
    PerezStable, E
    PHARMACOGENETICS, 1996, 6 (03): : 239 - 242
  • [50] Effect of tolterodine on sleep structure modulated by CYP2D6 genotype
    Diefenbach, Konstanze
    Jaeger, Katrin
    Wollny, Agnes
    Penzel, Thomas
    Fietze, Ingo
    Roots, Ivar
    SLEEP MEDICINE, 2008, 9 (05) : 579 - 582